PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Clinical Immunology and Rheumatology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India. durgapmisra@gmail.com.\', \'Department of Clinical Immunology and Rheumatology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India.\', \'Departments of Rheumatology and Research and Development, Dudley Group NHS Foundation Trust (Teaching Trust of the University of Birmingham, UK), Russells Hall Hospital, Dudley, West Midlands, UK.\', \'Department of Internal Medicine #2, Danylo Halytsky Lviv National Medical University, Lviv, Ukraine.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1007/s10067-020-05073-9
?:hasPublicationType
?:journal
  • Clinical rheumatology
is ?:pmid of
?:pmid
?:pmid
  • 32277367
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.93
?:rankingScore_hIndex
  • 71
is ?:relation_isRelatedTo_publication of
?:title
  • Rheumatologists\' perspective on coronavirus disease 19 (COVID-19) and potential therapeutic targets.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all